Cargando…
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101331/ https://www.ncbi.nlm.nih.gov/pubmed/33958800 http://dx.doi.org/10.1038/s41591-021-01372-z |
| _version_ | 1783688943272722432 |
|---|---|
| author | Barrett, Jordan R. Belij-Rammerstorfer, Sandra Dold, Christina Ewer, Katie J. Folegatti, Pedro M. Gilbride, Ciaran Halkerston, Rachel Hill, Jennifer Jenkin, Daniel Stockdale, Lisa Verheul, Marije K. Aley, Parvinder K. Angus, Brian Bellamy, Duncan Berrie, Eleanor Bibi, Sagida Bittaye, Mustapha Carroll, Miles W. Cavell, Breeze Clutterbuck, Elizabeth A. Edwards, Nick Flaxman, Amy Fuskova, Michelle Gorringe, Andrew Hallis, Bassam Kerridge, Simon Lawrie, Alison M. Linder, Aline Liu, Xinxue Madhavan, Meera Makinson, Rebecca Mellors, Jack Minassian, Angela Moore, Maria Mujadidi, Yama Plested, Emma Poulton, Ian Ramasamy, Maheshi N. Robinson, Hannah Rollier, Christine S. Song, Rinn Snape, Matthew D. Tarrant, Richard Taylor, Stephen Thomas, Kelly M. Voysey, Merryn Watson, Marion E. E. Wright, Daniel Douglas, Alexander D. Green, Catherine M. Hill, Adrian V. S. Lambe, Teresa Gilbert, Sarah Pollard, Andrew J. |
| author_facet | Barrett, Jordan R. Belij-Rammerstorfer, Sandra Dold, Christina Ewer, Katie J. Folegatti, Pedro M. Gilbride, Ciaran Halkerston, Rachel Hill, Jennifer Jenkin, Daniel Stockdale, Lisa Verheul, Marije K. Aley, Parvinder K. Angus, Brian Bellamy, Duncan Berrie, Eleanor Bibi, Sagida Bittaye, Mustapha Carroll, Miles W. Cavell, Breeze Clutterbuck, Elizabeth A. Edwards, Nick Flaxman, Amy Fuskova, Michelle Gorringe, Andrew Hallis, Bassam Kerridge, Simon Lawrie, Alison M. Linder, Aline Liu, Xinxue Madhavan, Meera Makinson, Rebecca Mellors, Jack Minassian, Angela Moore, Maria Mujadidi, Yama Plested, Emma Poulton, Ian Ramasamy, Maheshi N. Robinson, Hannah Rollier, Christine S. Song, Rinn Snape, Matthew D. Tarrant, Richard Taylor, Stephen Thomas, Kelly M. Voysey, Merryn Watson, Marion E. E. Wright, Daniel Douglas, Alexander D. Green, Catherine M. Hill, Adrian V. S. Lambe, Teresa Gilbert, Sarah Pollard, Andrew J. |
| author_sort | Barrett, Jordan R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8101331 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81013312021-05-07 Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Barrett, Jordan R. Belij-Rammerstorfer, Sandra Dold, Christina Ewer, Katie J. Folegatti, Pedro M. Gilbride, Ciaran Halkerston, Rachel Hill, Jennifer Jenkin, Daniel Stockdale, Lisa Verheul, Marije K. Aley, Parvinder K. Angus, Brian Bellamy, Duncan Berrie, Eleanor Bibi, Sagida Bittaye, Mustapha Carroll, Miles W. Cavell, Breeze Clutterbuck, Elizabeth A. Edwards, Nick Flaxman, Amy Fuskova, Michelle Gorringe, Andrew Hallis, Bassam Kerridge, Simon Lawrie, Alison M. Linder, Aline Liu, Xinxue Madhavan, Meera Makinson, Rebecca Mellors, Jack Minassian, Angela Moore, Maria Mujadidi, Yama Plested, Emma Poulton, Ian Ramasamy, Maheshi N. Robinson, Hannah Rollier, Christine S. Song, Rinn Snape, Matthew D. Tarrant, Richard Taylor, Stephen Thomas, Kelly M. Voysey, Merryn Watson, Marion E. E. Wright, Daniel Douglas, Alexander D. Green, Catherine M. Hill, Adrian V. S. Lambe, Teresa Gilbert, Sarah Pollard, Andrew J. Nat Med Author Correction Nature Publishing Group US 2021-05-06 2021 /pmc/articles/PMC8101331/ /pubmed/33958800 http://dx.doi.org/10.1038/s41591-021-01372-z Text en © The Author(s), under exclusive licence to Springer Nature America, Inc. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Author Correction Barrett, Jordan R. Belij-Rammerstorfer, Sandra Dold, Christina Ewer, Katie J. Folegatti, Pedro M. Gilbride, Ciaran Halkerston, Rachel Hill, Jennifer Jenkin, Daniel Stockdale, Lisa Verheul, Marije K. Aley, Parvinder K. Angus, Brian Bellamy, Duncan Berrie, Eleanor Bibi, Sagida Bittaye, Mustapha Carroll, Miles W. Cavell, Breeze Clutterbuck, Elizabeth A. Edwards, Nick Flaxman, Amy Fuskova, Michelle Gorringe, Andrew Hallis, Bassam Kerridge, Simon Lawrie, Alison M. Linder, Aline Liu, Xinxue Madhavan, Meera Makinson, Rebecca Mellors, Jack Minassian, Angela Moore, Maria Mujadidi, Yama Plested, Emma Poulton, Ian Ramasamy, Maheshi N. Robinson, Hannah Rollier, Christine S. Song, Rinn Snape, Matthew D. Tarrant, Richard Taylor, Stephen Thomas, Kelly M. Voysey, Merryn Watson, Marion E. E. Wright, Daniel Douglas, Alexander D. Green, Catherine M. Hill, Adrian V. S. Lambe, Teresa Gilbert, Sarah Pollard, Andrew J. Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses |
| title | Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses |
| title_full | Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses |
| title_fullStr | Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses |
| title_full_unstemmed | Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses |
| title_short | Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses |
| title_sort | author correction: phase 1/2 trial of sars-cov-2 vaccine chadox1 ncov-19 with a booster dose induces multifunctional antibody responses |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101331/ https://www.ncbi.nlm.nih.gov/pubmed/33958800 http://dx.doi.org/10.1038/s41591-021-01372-z |
| work_keys_str_mv | AT barrettjordanr authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT belijrammerstorfersandra authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT doldchristina authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT ewerkatiej authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT folegattipedrom authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT gilbrideciaran authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT halkerstonrachel authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT hilljennifer authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT jenkindaniel authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT stockdalelisa authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT verheulmarijek authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT aleyparvinderk authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT angusbrian authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT bellamyduncan authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT berrieeleanor authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT bibisagida authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT bittayemustapha authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT carrollmilesw authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT cavellbreeze authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT clutterbuckelizabetha authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT edwardsnick authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT flaxmanamy authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT fuskovamichelle authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT gorringeandrew authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT hallisbassam authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT kerridgesimon authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT lawriealisonm authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT linderaline authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT liuxinxue authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT madhavanmeera authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT makinsonrebecca authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT mellorsjack authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT minassianangela authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT mooremaria authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT mujadidiyama authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT plestedemma authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT poultonian authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT ramasamymaheshin authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT robinsonhannah authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT rollierchristines authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT songrinn authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT snapematthewd authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT tarrantrichard authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT taylorstephen authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT thomaskellym authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT voyseymerryn authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT watsonmarionee authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT wrightdaniel authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT douglasalexanderd authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT greencatherinem authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT hilladrianvs authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT lambeteresa authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT gilbertsarah authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT pollardandrewj authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses AT authorcorrectionphase12trialofsarscov2vaccinechadox1ncov19withaboosterdoseinducesmultifunctionalantibodyresponses |